<abstract xmlns="http://www.w3.org/1999/xhtml"><bold>Background:</bold> Pelvic exenteration is an ultra-radical surgical procedure described by Brunschwig in 1948, which attempts to surgically cure patients with recurrent pelvic cancer after radiotherapy. Several variants of pelvic exenteration are described that allow a more limited or extensive resection, depending on the stage of the disease.<bold>Case report:</bold> We report the case of a 54-year-old woman, who was diagnosed with a tumoral rectovaginal fistula after a recurrent cervical cancer that had been treated with a total hysterectomy with bilateral adnexectomy and a left percutaneous nephrostomy, as well as interaortocaval lymph node resection. The patient had undergone a supralevator total pelvic exenteration with pelvic and interaortocaval lymphadenectomy. The reconstruction process included right ureterostomy, left nephrostomy, and colocutaneous anal anastomosis (Parks procedure).<bold>Conclusions:</bold> Supralevator total pelvic exenteration provides hope for cure in patients with pelvic malignancies that reappear after radiotherapy. The restoration of the digestive tract and avoiding colostomy with a colocutaneous anastomosis increases the quality of life in these cases.</abstract>

Background: Pelvic exenteration is an ultra-radical surgical procedure described by Brunschwig in 1948, which attempts to surgically cure patients with recurrent pelvic cancer after radiotherapy. Several variants of pelvic exenteration are described that allow a more limited or extensive resection, depending on the stage of the disease.Case report: We report the case of a 54-year-old woman, who was diagnosed with a tumoral rectovaginal fistula after a recurrent cervical cancer that had been treated with a total hysterectomy with bilateral adnexectomy and a left percutaneous nephrostomy, as well as interaortocaval lymph node resection. The patient had undergone a supralevator total pelvic exenteration with pelvic and interaortocaval lymphadenectomy. The reconstruction process included right ureterostomy, left nephrostomy, and colocutaneous anal anastomosis (Parks procedure).Conclusions: Supralevator total pelvic exenteration provides hope for cure in patients with pelvic malignancies that reappear after radiotherapy. The restoration of the digestive tract and avoiding colostomy with a colocutaneous anastomosis increases the quality of life in these cases.

Supralevator Total Pelvic Exenteration Without Colostomy — Case Report

Clinic of Surgery I, County Emergency Clinical Hospital

Clinic of Urology, County Clinical Hospital

Clinic of Obstetrics and Gynecology I, County Emergency Clinical Hospital

Journal of Interdisciplinary Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"Supralevator Total Pelvic Exenteration Without Colostomy \u2014 Case Report"}

Background: Pelvic exenteration is an ultra-radical surgical procedure described by Brunschwig in 1948, which attempts to surgically cure patients with...

Supralevator Total Pelvic Exenteration Without Colostomy — Case Report

Pubblicato online: 08 nov 2017

Pagine: 258 - 261

Ricevuto: 15 giu 2017

Accettato: 23 lug 2017

DOI: https://doi.org/10.1515/jim-2017-0060

Parole chiave
supralevator pelvic exenteration, colocutaneous anastomosis, cervical cancer

© 2017 Marian Botoncea et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Supralevator Total Pelvic Exenteration Without Colostomy — Case Report

Pubblicato online: 08 nov 2017

Pagine: 258 - 261

Ricevuto: 15 giu 2017

Accettato: 23 lug 2017

DOI: https://doi.org/10.1515/jim-2017-0060

Parole chiavesupralevator pelvic exenteration, colocutaneous anastomosis, cervical cancer

© 2017 Marian Botoncea et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Parole chiave
supralevator pelvic exenteration, colocutaneous anastomosis, cervical cancer